“Efficacy of Dapagliflozin Versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus”. 2026. World Journal of Current Medical and Pharmaceutical Research 8 (2): 185-89. https://doi.org/10.37022/wjcmpr.v8i2.415.